Skip to main content
OpenTrials
Completed

NCT Number: NCT03513276

Effect of Local Infiltration Anesthesia in a Hip Arthroplasty Fast Track Program.

Fast-track programs in Orthopaedic Surgery require early motion that can only be achieved by optimal pain management protocols. Multimodal analgesia protocols including local infiltration anesthesia (LIA) have obtained excellent results in fast-track programs involving Total Knee Arthroplasty but further research and data is needed in Total Hip Arthoplasty programs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hip Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Osteoarthritis Osteoarthritis, Hip Rheumatic Diseases

Age range

20 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hospital Universitari Mutua Terrassa

Terrassa, Barcelona, 08221, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hip osteoarthritis requiring Total Hip Replacement

Exclusion criteria

  • Mental Disorders
  • contraindications for epidural anesthesia
  • Neurologic disorders that could interfere with pain evaluation
  • allergy to drugs in multimodal analgesic protocol

Treatment and study plan

100cc of 2% ropivacaine

Drug

Multimodal analgesia + Local infiltration anesthesia

Saline Solution

Drug

Multimodal analgesia + Saline solution

Adrenaline 10mcg/ml

Drug

Primary outcomes

  1. Pain measured in Visual Analog Scale

    Time frame: Up to 48h postoperatively

    Pain assesed using Visual Analog Scale ( Scoring from 0 to 10)

Secondary outcomes

  1. Length of hospital stay

    Time frame: Up to 1 week

    Length of hospital stay measured in days

  2. Analgesic requirements

    Time frame: Up to 1 week

    Analgesia requirements needed besides protocol medication Measured in miligrams of drug required(Sevredol) Analgesia required by patient

  3. Complications

    Time frame: Up to 1 week

    Wound dehiscence, Infection, reoperation, dislocation.

Sponsors and collaborators

Lead sponsor

Hospital Mutua de Terrassa

Other

Registry information

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
May 1, 2018
Registry last updated
May 1, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.